All news

Treg pioneer Bluestone joins Vie Ventures as it builds autoimmune portfolio

BioCentury's coverage of Jeff Bluestone joining Vie Ventures as Managing Director.

BioCentury reported on Jeff Bluestone, PhD, joining Vie Ventures as Managing Director as the firm builds its autoimmune portfolio. The full article is available on BioCentury; a reprint of the coverage is shown below.

BioCentury — Reprint — page 1
BioCentury — Reprint — page 2
BioCentury — Reprint — page 3
BioCentury — ReprintOpen original

Building the future of autoimmune therapeutics.

Whether you are a prospective investor, a strategic collaborator, or a company creating next-generation therapies, we would be glad to connect.

Or email us directly at contact@vieventures.com.